Kyowa Kirin to Build First US Pharma Operations
Japan-based pharmaceutical company Kyowa Kirin plans to build a $200 million biologics manufacturing center in Sanford, North Carolina, creating 102 jobs. This will be the company’s first North American pharmaceutical manufacturing operation, expected to create 102 jobs.
“Establishing a new center of excellence for biologics manufacturing in North America is a testament to the promising potential we see in our pipeline,” said Paul Testa, Kyowa Kirin’s executive vice president Supply Chain & Manufacturing, North America. “We believe the Sanford facility will become a vital part of our global manufacturing network – helping us train employees, deliver medicines with life-changing value, and support our future growth as a region and as a global business.”
The project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) awarded to Kyowa Kirin North America Manufacturing.
Kyowa Kirin expects to complete the project in four years.
© REB Images/Getty Images
